Effects of single and repeated doses of omeprazole on gastric acid and pepsin secretion in man.
- 1 July 1984
- Vol. 25 (7) , 707-710
- https://doi.org/10.1136/gut.25.7.707
Abstract
The effects of omeprazole, a substituted benzimidazole, on gastric acid and pepsin secretion have been studied in twelve healthy subjects. From six to eight hours after a single oral dose of 30 mg, there was a 66% reduction in basal acid output, and a 71.2% reduction in pentagastrin stimulated acid output. A single dose of 60 mg produced a 91.7% reduction in basal acid output and a 95.3% reduction in pentagastrin stimulated acid output. After seven days treatment with 30 or 60 mg daily, there was almost 100% inhibition of both basal and pentagastrin stimulated acid output. Omeprazole did not significantly affect pepsin secretion which is in keeping with its proposed mode of action, as an inhibitor of the H+/K+-ATPase enzyme on the secretory membrane of the parietal cell. There were no side effects after omeprazole either with single or repeated dosing.Keywords
This publication has 12 references indexed in Scilit:
- Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man.Gut, 1983
- EFFECT OF REPEATED, ONCE DAILY, ORAL OMEPRAZOLE ON GASTRIC SECRETIONThe Lancet, 1983
- REDUCTION OF GASTRIC HYPERSECRETION IN ZOLLINGER-ELLISON SYNDROME WITH OMEPRAZOLEThe Lancet, 1983
- CONTROL OF ACUTE ZOLLINGER-ELLISON SYNDROME WITH INTRAVENOUS OMEPRAZOLEThe Lancet, 1982
- Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+) ATPaseNature, 1981
- INHIBITION OF PENTAGASTRIN-STIMULATED AND NOCTURNAL GASTRIC SECRETION BY RANITIDINEThe Lancet, 1979
- Basal gastric secretion: reproducibility and relationship with duodenal ulceration.Gut, 1977
- Pharmacological evaluation of cimetidine, a new histamine H2‐receptor antagonist, in healthy man.British Journal of Clinical Pharmacology, 1975
- Positioning of Subject and of Nasogastric Tube during a Gastric Secretion StudyBMJ, 1970
- Continuous intravenous pentagastrin as a stimulant of maximal gastric acid secretion.Gut, 1969